Because better subtyping of early stage colorectal cancer is particularly crucial for risk-stratifying patients prior to treatment, we examined whether STAT1 protein expression had prognostic value in early stage disease (stages I and II). The gene discussed is STAT1; the disease is colorectal cancer.